Markets
XPH

RSI Alert: Pacira Pharmaceuticals Now Oversold

Shutterstock photo
Shutterstock photo

Shutterstock photo

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Pacira Pharmaceuticals Inc. (Symbol: PCRX) entered into oversold territory, hitting an RSI reading of 23.0, after changing hands as low as $29.35 per share. By comparison, the current RSI reading of the S&P 500 ETF ( SPY ) is 54.2. A bullish investor could look at PCRX's 23.0 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of PCRX shares:

Pacira Pharmaceuticals Inc. 1 Year Performance Chart

Looking at the chart above, PCRX's low point in its 52 week range is $29.35 per share, with $58.95 as the 52 week high point - that compares with a last trade of $30.70.

According to the ETF Finder at ETF Channel, PCRX makes up 1.77% of the SPDR S&P Pharmaceuticals ETF (Symbol: XPH) which is trading higher by about 0.6% on the day Friday.

Find out what 9 other oversold stocks you need to know about »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

XPH PCRX SPY

Latest Markets Videos